Efficacy and safety of manufactured Chinese herbal formula for cervical radiculopathy: a systematic review with meta-analysis and trial sequential analysis
Abstract
Background: Clinical trials have been widely reported for the application of manufactured Chinese herbal formula (MCHF) in patients with Cervical Radiculopathy (CR). Existing published systematic reviews are confined to assessing the therapeutic efficacy of individual MCHF types in the management of CR, whereas a comprehensive, holistic evaluation of both efficacy and safety outcomes across the full spectrum of MCHF remains lacking.
Objective: To assess the efficacy and safety of MCHF for CR.
Methods: We searched six databases and three registries from inception to 30 September 2024. Eligible randomized controlled trials investigating the efficacy of MCHF for CR were included. Data extraction, methodological assessment, and meta-analyses were conducted according to the Cochrane standards.
Results: We included 14 studies, covering 8 types of MCHF with a total of 1,576 participants. MCHF may reduce the pain of VAS in CR. In subgroup meta-analysis, MCHF may be more efficacious in relieving pain than the placebo. MCHF combined with conventional oral drugs were more efficacious than conventional oral drugs alone. Trial sequential analysis (TSA) indicated that the sample sizes were adequate to confirm the reliability of the aforementioned findings. No significant difference in therapeutic efficacy was observed between MCHF and conventional oral medications, but TSA indicated that further large-scale RCTs are required to validate these results. In terms of the Neck Disability Index…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,576 participants or records.
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.